BlackRock Institutional Trust’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $17.6M | Buy |
221,266
+15,351
| +7% | +$1.22M | ﹤0.01% | 2064 |
|
|
2016
Q3 | $14.4M | Sell |
205,915
-31,795
| -13% | -$2.23M | ﹤0.01% | 2105 |
|
|
2016
Q2 | $9.22M | Buy |
237,710
+39
| +0% | +$1.51K | ﹤0.01% | 2335 |
|
|
2016
Q1 | $9.63M | Buy |
237,671
+26,882
| +13% | +$1.09M | ﹤0.01% | 2276 |
|
|
2015
Q4 | $18.7M | Sell |
210,789
-24,844
| -11% | -$2.2M | ﹤0.01% | 1917 |
|
|
2015
Q3 | $17.4M | Buy |
235,633
+53,614
| +29% | +$3.97M | ﹤0.01% | 1929 |
|
|
2015
Q2 | $14.7M | Buy |
182,019
+149,486
| +459% | +$12.1M | ﹤0.01% | 2132 |
|
|
2015
Q1 | $1.36M | Buy |
+32,533
| New | +$1.36M | ﹤0.01% | 3251 |
|
|
2014
Q2 | – | Sell |
-28,510
| Closed | -$364K | – | 4018 |
|
|
2014
Q1 | $364K | Buy |
+28,510
| New | +$364K | ﹤0.01% | 3604 |
|